BioAmber Appoints Roland Berger Partner as New CEO

BioAmber Inc (BIOA) has appointment Richard Eno as its new chief executive officer (CEO), and new member of the board, effective September 18th, 2017.

Most recently in 2015, Eno joined Roland Berger, a global management consultancy as a partner in the Boston office’s chemicals & oil competence centre.

Eno has over 30 years of related management experience in the energy, chemicals, biotechnology and materials industries, including over five years as president, CEO and board member of a publicly traded industrial biotechnology company.

Rick began his career in Chevron's chemical operations with roles of increasing responsibility in engineering, manufacturing and construction operations. He then entered management consulting where he specialized in addressing critical strategic and operational issues facing company leadership in the chemical and energy industries. In 2008, he took up leadership of Metabolix, an industrial biotechnology company commercializing a range of unique bio-based, biodegradable polymers.

He currently serves on the president's Council for Ceres, a non-profit promoting a sustainable future; the alumni advisory board for Cornell University's School of Chemical and Biomolecular Engineering; and on the alumni advisory board for Cornell's Atkinson's centre for a sustainable future.

"The board is pleased to have found an individual with an ideal industry background as well as public company experience to assume leadership of BioAmber. Rick is uniquely qualified to lead BioAmber successfully into the future," said Ray Land, BioAmber's chairman of the board.

"I am enthused to joining the BioAmber team. The company's bio-succinic technology operates superbly at scale, there is a rich pipeline of attractive customer opportunities, and a world class team in place. I look forward to leading the growth of this highly innovative company," added Eno.